DOSE RECONSTRUCTION FOR THE FERNALD NUCLEAR FACILITY: A REVIEW OFTASK 4

Committee on an Assessment of CDC Radiation Studies

Board on Radiation Effects Research

Commission on Life Sciences

National Research Council

NATIONAL ACADEMY PRESS
Washington, D.C.
1994



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page R1
DOSE RECONSTRUCTION FOR THE FERNALD NUCLEAR FACILITY: A REVIEW OFTASK 4 DOSE RECONSTRUCTION FOR THE FERNALD NUCLEAR FACILITY: A REVIEW OFTASK 4 Committee on an Assessment of CDC Radiation Studies Board on Radiation Effects Research Commission on Life Sciences National Research Council NATIONAL ACADEMY PRESS Washington, D.C. 1994

OCR for page R1
DOSE RECONSTRUCTION FOR THE FERNALD NUCLEAR FACILITY: A REVIEW OFTASK 4 NATIONAL ACADEMY PRESS 2101 CONSTITUTION AVENUE, N.W.,WASHINGTON, D.C. 20418 The project that is the subject of this report was approved by the governing board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competencies and with regard for appropriate balance. This report has been reviewed by a group other than the authors according to procedures approved by a Report Review Committee consisting of the members of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. This project was prepared under grant 200-91-0951 between the National Academy of Sciences and the Centers for Disease Control and Prevention. Limited number of copies available from the Board on Radiation Effects Research, Commission on Life Sciences, National Research Council, 2101 Constitution Avenue NW., Washington, D.C. 20418 Copyright 1994 by the National Academy of Sciences . All rights reserved. Printed in the United States of America

OCR for page R1
DOSE RECONSTRUCTION FOR THE FERNALD NUCLEAR FACILITY: A REVIEW OFTASK 4 COMMITTEE ON AN ASSESSMENT OF CDC RADIATION STUDIES WILLIAM J. SCHULL (Chairman), University of Texas, Houston, Texas STEPHEN A. BENJAMIN, Colorado State University, Fort Collins, Colorado ANDRÉ BOUVILLE, National Cancer Institute, Bethesda, Maryland GEOFFREY G. EICHHOLZ, Georgia Institute of Technology, Atlanta, Georgia J. CHARLES JENNETT, Clemson University, Clemson, South Carolina LEEKA I. KHEIFETS, Electric Power Research Institute, Palo Alto, California JAMES E. MARTIN, University of Michigan, Ann Arbor, Michigan CHRISTOPHER B. NELSON, U.S. Environmental Protection Agency, Washington, D.C. HENRY D. ROYAL, Washington University Medical Center, St. Louis, Missouri ROY E. SHORE, New York University Medical Center, New York, New York ROBERT G. THOMAS, Argonne National Laboratory (ret.), Argonne, Illinois HENRY N. WAGNER, Jr., The Johns Hopkins Medical Institutes, Baltimore, Maryland JAMES M. WALL, The Christian Century, Chicago, Illinois National Research Council Staff EVAN B. DOUPLE, Study Director MAURITA DOW-MASSEY, Project Assistant DORIS E. TAYLOR, Staff Assistant SPONSOR'S PROJECT OFFICER JAMES M. SMITH, Centers for Disease Control and Prevention

OCR for page R1
DOSE RECONSTRUCTION FOR THE FERNALD NUCLEAR FACILITY: A REVIEW OFTASK 4 BOARD ON RADIATION EFFECTS RESEARCH WARREN K. SINCLAIR (Chairman), National Council on Radiation Protection and Measurements (ret.), Bethesda, Maryland DOUGLAS GRAHN, Argonne National Laboratory (ret.), Madison, Indiana (member until June 30, 1994) ERIC J. HALL, Columbia University, New York, New York (member until June 30, 1994) MAUREEN M. HENDERSON, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington LEONARD S. LERMAN, Massachusetts Institute of Technology, Cambridge, Massachusetts JOHN B. LITTLE, Harvard University, Cambridge, Massachusetts JONATHAN M. SAMET, The Johns Hopkins University, Baltimore, Maryland WILLIAM J. SCHULL, University of Texas, Houston, Texas (member as of July 1, 1994) THOMAS S. TENFORDE, Battelle, Pacific Northwest Laboratories, Richland, Washington SUSAN S. WALLACE, University of Vermont, Burlington, Vermont (member as of July 1, 1994) H. RODNEY WITHERS, University of California Medical Center, Los Angeles, California National Research Council Staff JOHN D. ZIMBRICK, Director EVAN B. DOUPLE, Senior Program Officer CHARLES W. EDINGTON, Director, RERFP LARRY H. TOBUREN, Senior Program Officer CATHERINE S. BERKLEY, Administrative Associate MAURITA DOW-MASSEY, Project Assistant DORIS E. TAYLOR, Staff Assistant LARA V. ADAMO, Project Assistant/Secretary (as of October 17, 1994)

OCR for page R1
DOSE RECONSTRUCTION FOR THE FERNALD NUCLEAR FACILITY: A REVIEW OFTASK 4 COMMISSION ON LIFE SCIENCES THOMAS D. POLLARD (Chairman), Johns Hopkins Medical School, Baltimore, Maryland BRUCE N. AMES, University of California, Berkeley, California JOHN C. BAILAR, III, McGill University, Montreal, Quebec, Canada J. MICHAEL BISHOP, University of California Medical Center, San Francisco, California JOHN E. BURRIS, Marine Biological Laboratory, Woods Hole, Massachusetts MICHAEL T. CLEGG, University of California, Riverside, California GLENN A. CROSBY, Washington State University, Pullman, Washington LEROY E. HOOD, University of Washington, Seattle, Washington MARIAN E. KOSHLAND, University of California, Berkeley, California RICHARD E. LENSKI, Michigan State University, East Lansing, Michigan EMIL A. PFITZER, Hoffmann-La Roche Inc., Nutley, New Jersey MALCOLM C. PIKE, University of Southern California, School of Medicine, Los Angeles, California HENRY C. PITOT III, University of Wisconsin, Madison, Wisconsin PAUL G. RISSER, Miami University, Oxford, Ohio JONATHAN M. SAMET, The Johns Hopkins University, Baltimore, Maryland HAROLD M. SCHMECK, Jr., Armonk, New York CARLA J. SHATZ, University of California, Berkeley, California SUSAN S. TAYLOR, University of California San Diego, La Jolla, California P. ROY VAGELOS, Merck & Co., Inc., Whitehouse Station, New Jersey JOHN L. VANDEBERG, Southwest Foundation for Biomedical Research, San Antonio, Texas TORSTEN N. WIESEL, Rockefeller University, New York, New York National Research Council Staff PAUL GILMAN, Executive Director ALVIN G. LAZEN, Associate Executive Director

OCR for page R1
DOSE RECONSTRUCTION FOR THE FERNALD NUCLEAR FACILITY: A REVIEW OFTASK 4 The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Bruce M. Alberts is president of the National Academy of Sciences. The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. Robert M. White is the president of the National Academy of Engineering. The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Kenneth I. Shine is president of the Institute. The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy's purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Bruce M. Alberts and Dr. Robert M. White are chairman and vice chairman, respectively, of the National Research Council.

OCR for page R1
DOSE RECONSTRUCTION FOR THE FERNALD NUCLEAR FACILITY: A REVIEW OFTASK 4 PREFACE The Committee on an Assessment of CDC Radiation Studies was directed to perform a task that is unusual for National Research Council (NRC) committees: to advise an agency (the Centers for Disease Control, CDC) about reports (on the Fernald Environmental Management Project, FEMP–formerly called the Feed Materials Production Center) that are almost completed but might change as a result of additional work by the preparer (Radiological Assessments Corporation, RAC) or as a result of the preparer's responses to external review. The NRC report that follows cannot be considered either an approval or disapproval of the final RAC reports, which have not been issued. Rather, like the committee's earlier report, Dose Reconstruction for the Fernald Nuclear Facility (National Research Council, 1992), this is a commentary on the current version of the RAC report. The need to comment arises from two circumstances: First, CDC is charged with evaluating human exposure in the vicinity of several nuclear facilities around the country, and the evaluation of FEMP could serve as a model for other studies; this committee 's comments might help to refine procedures for the performance of other studies that start in the near future. Second, there is considerable public concern about the Fernald nuclear facility and a need to accelerate the evaluation of the situation there. The need for expedited action accounts for this committee's undertaking to comment on draft reports, rather than waiting for the submission of final reports. The committee members wish to thank the members of the NRC staff who worked with us, especially Doris Taylor and Maurita Dow-Massey for their preparation of several drafts of this report and for their help in the administration of the committee's work. Mrs. Kate Kelly is thanked for her editorial review of this report. William J. Schull Chairman

OCR for page R1
DOSE RECONSTRUCTION FOR THE FERNALD NUCLEAR FACILITY: A REVIEW OFTASK 4 This page in the original is blank.